Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.44 USD | -0.85% | +2.86% | -11.90% |
Apr. 09 | Sector Update: Health Care Stocks Edge Higher Pre-Bell Tuesday | MT |
Apr. 09 | Alkermes Says Potential Narcolepsy Drug Improves Wakefulness in Phase 1b Study | MT |
Financials (USD)
Sales 2024 * | 1.52B | Sales 2025 * | 1.52B | Capitalization | 4.13B |
---|---|---|---|---|---|
Net income 2024 * | 352M | Net income 2025 * | 331M | EV / Sales 2024 * | 2.2 x |
Net cash position 2024 * | 791M | Net cash position 2025 * | 1.17B | EV / Sales 2025 * | 1.94 x |
P/E ratio 2024 * |
12
x | P/E ratio 2025 * |
13.2
x | Employees | 2,100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.59% |
Latest transcript on Alkermes plc
1 day | -0.85% | ||
1 week | +2.86% | ||
Current month | -9.72% | ||
1 month | -10.51% | ||
3 months | -12.78% | ||
6 months | +4.22% | ||
Current year | -11.90% |
Managers | Title | Age | Since |
---|---|---|---|
Richard Pops
CEO | Chief Executive Officer | 62 | 91-01-31 |
Blair Jackson
DFI | Director of Finance/CFO | 51 | 98-12-31 |
Shane Cooke
PSD | President | 61 | 11-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Pops
CEO | Chief Executive Officer | 62 | 91-01-31 |
Nancy Snyderman
BRD | Director/Board Member | 72 | 16-05-25 |
Brian McKeon
BRD | Director/Board Member | 61 | 20-12-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
15.32% | 215 M€ | +12.27% | - | |
2.65% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 24.44 | -0.85% | 1,313,771 |
24-04-24 | 24.65 | +1.61% | 1,737,019 |
24-04-23 | 24.26 | +0.79% | 1,245,764 |
24-04-22 | 24.07 | +0.92% | 1,708,265 |
24-04-19 | 23.85 | +0.38% | 2,414,813 |
Delayed Quote Nasdaq, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.90% | 4.13B | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+45.26% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- ALKS Stock